A new frontier in breast cancer: Can small molecules in the blood predict outcome?

The research team has identified 27 small molecules called micro RNAs that are associated with very aggressive triple negative breast cancer subtype.

In this new study they will assess the use of these small molecules as indicators of therapy response and outcome response in breast cancer.

Researchers

Research Area

Project type

Project Grant

Year of funding

2014

Our Role & Impact